CHICAGO, May 15, 2025--(BUSINESS WIRE)--MAIA Biotechnology ... from the Phase 2 THIO-101 clinical trial was accepted for poster presentation at the 2025 Annual Meeting of the American Society ...

Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the publication of 3 abstracts for poster presentations at the American Association for ...

SAN FRANCISCO, May 22, 2024--(BUSINESS WIRE)--Vir Biotechnology ... This includes an oral presentation on June 8, which was originally accepted as a late-breaker poster, that will highlight ...

Adagene Inc. announced a poster presentation for the ASCO 2025 conference ... which can enhance visibility and credibility within the biotechnology community. The updated results of the Phase ...

SAN DIEGO, April 29, 2025 /PRNewswire/ -- NEUVOGEN, Inc. ("NEUVOGEN THERAPEUTICS" or "NEUVOGEN"), a San Diego based biotechnology company, will present data that its next generation whole tumor ...

MetaVia Inc. is a clinical-stage biotechnology company focused on transforming cardiometabolic diseases. The company is currently developing DA-1726 for the treatment of obesity and is developing ...

Additionally, two abstracts on another drug, AFM24, in combination with atezolizumab for treating non-small cell lung cancer (NSCLC) have been accepted for poster presentations. The oral ...

CHICAGO & TAIPEI, Taiwan--(BUSINESS WIRE)--TRACT Therapeutics and Taiwan Bio Therapeutics are pleased to announce a poster presentation ... a clinical-stage biotechnology company, and Taiwan ...

BioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through its contractual relationship with BioDuro-Sundia, a provider of ...

CHICAGO, May 15, 2025--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American ... the efficacy data from the Phase 2 THIO-101 clinical trial was accepted for poster presentation at the 2025 Annual ...